PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
FITC anti-human/mouse Cutaneous Lymphocyte Antigen (CLA), 100 tests
FITC anti-human/mouse Cutaneous Lymphocyte Antigen (CLA), 25 tests
FITC anti-human/mouse Granzyme B Recombinant, 100 tests
FITC anti-human/mouse Granzyme B Recombinant, 25 tests
FITC anti-human/mouse integrin β7, 100 tests
FITC anti-human/mouse integrin β7, 50 μg
FITC anti-human/mouse integrin β7, 500 μg
FITC anti-human/mouse ZAP-70 , 100 tests
FITC anti-human/mouse/rat CD278 (ICOS), 100 μg
FITC anti-human/mouse/rat CD278 (ICOS), 25 μg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 1 g
GoInVivo™ Purified anti-human CD152 (CTLA-4), 100 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 25 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 5 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 50 mg
GoInVivo™ Purified anti-human CD152 (CTLA-4), 500 mg